Latest Healthtech Startup Funding Rounds
Companies building technology for healthcare delivery, diagnosis, clinical workflows and patient access.
- Rounds
- 744 Jan 1 – Oct 24, 2026
- Disclosed funding
- $25.3B 606 disclosed amounts
- Median round
- $16M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| M Decodes cellular networks to advance human health | $20M | Undisclosed | Healthtech, Biotech | Sweden | Investors | |
| T Provides AI-powered digital diagnostics for anatomic and clinical pathology | $15M | Undisclosed | Healthtech | United States | Investors | |
| IS Develops projection-based clinical guidance platform for doctors | $8.4M | Seed | Healthtech | United States | Investors | |
| IH Develops technology and services for clinical research. | $77M | Series CSeries C+ | Healthtech | United States | Investors | |
| P Builds end-to-end prescription infrastructure for modern healthcare | $16M | Series A | Healthtech | United States | Investors | |
| AL Develops clinically-dosed daily supplements | Undisclosed | Friends & FamilyUndisclosed | Healthtech | Canada | Investors | |
| A AidocCompany profile Aidoc provides clinical AI software that helps hospitals analyze imaging, prioritize findings and coordinate follow-up care. Aidoc provides clinical AI software that helps hospitals analyze imaging, prioritize findings and coordinate follow-up care. | $150M | Series ESeries C+ | Healthtech | United States | Investors | |
| A AxoftCompany profile Develops implantable Brain-Computer Interfaces (iBCIs) for neurological disorders Develops implantable Brain-Computer Interfaces (iBCIs) for neurological disorders | $55M | Series A | Healthtech | United States | Investors | |
| VB Vivacta BiotechnologyCompany profile Develops in vivo CAR-T cell therapies for cancer and autoimmune diseases Develops in vivo CAR-T cell therapies for cancer and autoimmune diseases | $50M | Series A+Series A | Healthtech, Biotech | China | Investors | |
| T AI-powered clinical trial recruitment platform | $150K | Pre-SeedPre-seed | Healthtech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1General Catalyst
Baba, Disha (formerly Curelink), Thatch
23rounds2led - 2Y Combinator (YC)
Vitalize, Angle Health, Metriport
21rounds0led - 3Alumni Ventures
MintNeuro, Evvy, Hopscotch Primary Care
13rounds0led - 4Andreessen Horowitz (a16z)
Sharp Performance, General Medicine, Devoted Health
12rounds2led - 5Khosla Ventures
Even Healthcare, Abby Care, Rightway
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.